您当前的位置：
首页 >
文章列表页 >
Effect of Yifei Jianpi Prescription on Lipopolysaccharide-induced Lung Immune Inflammatory Response in Rats Based on STAT1/IRF3 Pathway
更新时间：2024-11-19

    • Effect of Yifei Jianpi Prescription on Lipopolysaccharide-induced Lung Immune Inflammatory Response in Rats Based on STAT1/IRF3 Pathway

    • “The latest research has found that Yifei Jianpi Formula can effectively alleviate lung tissue damage induced by lipopolysaccharide in pneumonia rats, improve lung immune inflammatory response, and its mechanism may be related to the inhibition of STAT1/IRF3 signaling pathway activation.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 1, Pages: 146-155(2025)

    • DOI：10.13422/j.cnki.syfjx.20241405    

      CLC： R285;R289;R256

    • Received：16 July 2024，

      Published Online：12 September 2024，

      Published：05 January 2025

    移动端阅览

  • YANG Hongjuan,YANG Yaru,YANG Yujie,et al.Effect of Yifei Jianpi Prescription on Lipopolysaccharide-induced Lung Immune Inflammatory Response in Rats Based on STAT1/IRF3 Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(01):146-155. DOI： 10.13422/j.cnki.syfjx.20241405.

  •  
  •  

0

Views

41

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Intervention of Acute Lung Injury by Traditional Chinese Medicine via Regulating Oxidative Stress： A Review
Research Progress on Qingwen Baidu Decoction and Its Active Ingredients in Prevention of Lung Injury
Impact of Maxing Kugan Decoction on Inflammatory Response and Apoptosis in Oleic Acid-induced Acute Lung Injury in Rats via p38 MAPK/NF-κB Signaling Pathway
Traditional Chinese Medicine Treats Acute Lung Injury by Modulating NLRP3 Inflammasome： A Review
Mechanism of Yantiao Prescription in Treating Lipopolysaccharide-induced Acute Lung Injury Based on Arachidonic Acid Metabolic Pathways

Related Author

LI Ang'ang
LIANG Xiao
LI Junmei
PENG Qing
LIU Jianxun
LIN Xiaojie
WEN Xianan
ZENG Qiaolin

Related Institution

Beijing Key Laboratory of Pharmacology of Chinese Materia Medica，Institute of Basic Medical Sciences of Xiyuan Hospital，China Academy of Chinese Medical Sciences
Chinese Medicine Research Institute，Guangdong Pharmaceutical University
School of Pharmacy，Guangdong Pharmaceutical University
College of Pharmacy，Guangzhou Health Science College
School of Health Science，Guangdong Pharmaceutical University
0